Get the Stockscreener App
6.71
6.02%
-0.43
Mind Medicine Inc stock is traded at $6.71, with a volume of 1.01M.
It is down -6.02% in the last 24 hours and up +1.67% over the past month.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
See More
Previous Close:
$7.14
Open:
$7.1
24h Volume:
1.01M
Relative Volume:
0.90
Market Cap:
$596.12M
Revenue:
$11.40B
Net Income/Loss:
$-95.73M
P/E Ratio:
-2.7388
EPS:
-2.45
Net Cash Flow:
$-64.37M
1W Performance:
-14.96%
1M Performance:
+1.67%
6M Performance:
-10.29%
1Y Performance:
-10.29%
1-Day Range:
$6.67
$7.17
1-Week Range:
$6.67
$8.05
52-Week Range:
$4.70
$10.44
Mind Medicine Inc Stock (MNMD) Company Profile
Name
Mind Medicine Inc
Sector
Industry
Phone
212-220-6633
Address
ONE WORLD TRADE CENTER, NEW YORK
Compare MNMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
6.71 | 596.12M | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.99 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
508.86 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.71 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
540.71 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
254.09 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-28-25 | Initiated | Evercore ISI | Outperform |
| Dec-20-24 | Initiated | Chardan Capital Markets | Buy |
| Oct-14-24 | Resumed | Leerink Partners | Outperform |
| Jul-24-24 | Initiated | ROTH MKM | Buy |
| May-29-24 | Initiated | Robert W. Baird | Outperform |
| Apr-15-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | Canaccord Genuity | Buy |
| Dec-09-22 | Resumed | ROTH Capital | Buy |
| Nov-16-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-26-22 | Initiated | Oppenheimer | Outperform |
| Aug-10-22 | Initiated | Cantor Fitzgerald | Overweight |
| May-04-22 | Initiated | ROTH Capital | Buy |
| Jun-28-21 | Initiated | Maxim Group | Buy |
View All
Mind Medicine Inc Stock (MNMD) Latest News
Mind Medicine at H.C. Wainwright: Strategic Advances in Neuropsychiatry By Investing.com - Investing.com Canada
Incannex forms joint venture with Mind Medicine Australia for clinic - Investing.com
Incannex forms joint venture with Mind Medicine Australia for clinic By Investing.com - Investing.com Nigeria
Incannex Healthcare Forms Joint Venture With Mind Medicine Australia To Expand Access To Psychedelic-Assisted Therapy - marketscreener.com
Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy - The Manila Times
Incannex Healthcare Inc. Forms Joint Venture with Mind Medicine Australia for Psychedelic-Assisted Therapy Clinic in Melbourne - Nasdaq
Groundbreaking Partnership: Incannex and Mind Medicine Launch Australia's Largest Psychedelic Therapy Center - Stock Titan
Mind Medicine Shareholders Approve Key Proposals at Annual Meeting - TipRanks
Analysts Offer Predictions for MNMD FY2026 Earnings - Defense World
MindMed Announces New Employee Inducement Grants | MNMD Stock News - GuruFocus
MindMed Announces New Employee Inducement Grants - FinancialContent
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Two Sigma Advisers LP Buys 5,400 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Ameriprise Financial Inc. Takes Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
(MNMD) Investment Report - news.stocktradersdaily.com
Millennium Management LLC Increases Stock Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
MindMed at Jefferies Global Healthcare Conference: Psychedelic Drug Advances - Investing.com Australia
MindMed at Jefferies Global Healthcare Conference: Psychedelic Drug Advances By Investing.com - Investing.com UK
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Sold by Two Sigma Investments LP - Defense World
Why Mind Medicine Gave Investors a Powerful Buzz in May - AOL.com
Bank of America Corp DE Reduces Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Why is Mind Medicine (MNMD) Stock Moving Today? - GuruFocus
Why Mind Medicine Gave Investors A Powerful Buzz In May - Barchart.com
Nuveen Asset Management LLC Acquires 8,856 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Wall Street Analysts Believe Mind Medicine MindMed (MNMD) Could Rally 237.47%: Here's is How to Trade - MSN
BNP Paribas Financial Markets Buys New Shares in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 6,182 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
MindMed Issues Inducement Grants to New Employees - TipRanks
MindMed Appoints Brandi Roberts as CFO to Drive Growth and Commercialization - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
MindMed (MNMD) Poised for Breakthrough in Anxiety Disorder Treat - GuruFocus
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Acquired by Deutsche Bank AG - Defense World
MindMed (MNMD) Poised for Breakthrough in Anxiety Disorder Treatment | MNMD Stock News - GuruFocus
Cantor Fitzgerald maintains Overweight rating on MindMed stock By Investing.com - Investing.com India
MindMed to Participate in June Investor Conferences | MNMD Stock News - GuruFocus
MindMed to Participate in June Investor Conferences - The Globe and Mail
MindMed's Brain Health Breakthroughs Take Center Stage at Jefferies and H.C. Wainwright Conferences - Stock Titan
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer - StreetInsider
Mind Medicine (MNMD) Appoints Brandi Roberts as New CFO | MNMD S - GuruFocus
MindMed appoints Brandi L. Roberts as CFO By Investing.com - Investing.com South Africa
MindMed Strengthens Executive Team with Appointment of Brandi Ro - GuruFocus
Mind Medicine Names Brandi Roberts CFO - marketscreener.com
Mindmed Strengthens Executive Team With Appointment Of Brandi Roberts As Chief Financial Officer - marketscreener.com
Mind Medicine Appoints New Chief Financial Officer - TipRanks
Mind Medicine (MNMD) Appoints Brandi Roberts as New CFO | MNMD Stock News - GuruFocus
MindMed appoints Brandi L. Roberts as CFO - Investing.com Australia
2 ‘Strong Buy’ Psychedelic Stocks To Scoop Up ASAP - Barchart.com
MindMed Appoints Brandi Roberts, CPA, as Chief Financial Officer - citybiz
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer | MNMD Stock News - GuruFocus
(MNMD) Trading Signals - news.stocktradersdaily.com
HC Wainwright Has Pessimistic Outlook of MNMD Q3 Earnings - Defense World
Mind Medicine Inc Stock (MNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):